Home » Economy » Big Pharma pushes back on Trump's drug pricing plan, Pfizer says it could cost US jobs
Big Pharma pushes back on Trump's drug pricing plan, Pfizer says it could cost US jobs
Fox Business Flash top headlines for July 28
Fox Business Flash top headlines are here. Check out what’s clicking on FoxBusiness.com.
The pharmaceutical industry is pushing back after President Trump signed four executive orders designed to slash drug prices last week, and Pfizer CEO Alfred Bourla said during an earnings call Tuesday that Trump's policies could cause the company to rethink U.S. expansion.
Continue Reading Below
TRUMP'S FOUR EXECUTIVE ORDERS TO LOWER DRUG PRICES: WHAT TO KNOW
The industry seems to take special issue with the Trump administration's “favored nations” policy that would require Medicare to purchase drugs at the same prices paid by foreign countries.
PhRMA, a pharmaceutical industry trade group, accused Trump of "disrupting" the fight against coronavirus.